Single Tablet HIV Combination Therapy Demonstrates Noninferiority When Switched From ...
|
Gilead reports its investigational single tablet of
bictegravir and lenacapavir was efficacious in people with HIV who are
virologically ... |
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.